Login / Signup

6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.

Jessica W WitherspoonRuhi P VasavadaMelissa R WaiteMonique SheltonIrene C ChrismerPaul G WakimMinal S JainCarsten G BönnemannKatherine G Meilleur
Published in: Orphanet journal of rare diseases (2018)
Clinical Trials.gov, NCT02362425 , Registered 13 February 2015-Prospectively registered.
Keyphrases
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label
  • drug induced